AstraZeneca (AZNCF) Stock Price, News & Analysis

Company Overview

AstraZeneca (OTCMKTS:AZNCF) is a global biopharmaceutical company that focuses on the discovery, development, manufacturing and commercialization of prescription medicines. The company’s research and development efforts are concentrated in three main therapeutic areas: oncology; cardiovascular, renal and metabolism; and respiratory, inflammation and autoimmunity. AstraZeneca’s product portfolio includes targeted therapies for lung and breast cancers, novel agents for heart failure and chronic kidney disease, and inhaled treatments for asthma and chronic obstructive pulmonary disease.

The company was formed in 1999 through the merger of Sweden’s Astra AB and the United Kingdom’s Zeneca Group, creating one of the world’s largest pharmaceutical firms. AstraZeneca is headquartered in Cambridge, England, and operates major research centers in the United Kingdom, the United States, Sweden and China. Its commercial organization spans more than 100 countries across North and South America, Europe, Asia Pacific, the Middle East and Africa, enabling broad access to its medicines.

Under the leadership of Chief Executive Officer Pascal Soriot since 2012, AstraZeneca has pursued a strategy of innovation and external collaboration. The company has established numerous strategic alliances with academic institutions, biotechnology firms and governmental agencies to accelerate the development of new therapies. Its investments in biopharmaceutical research have yielded several breakthrough approvals in recent years, reinforcing its position in key markets and therapeutic areas.

Key Stats

• Today's Range: $184.95 to $187.10
• 50-Day Range: $187.10 to $187.10
• 52-Week Range: $122.26 to $195.00
• Volume: N/A
• Average Volume: 1,957 shs
• Market Capitalization: N/A
• P/E Ratio: 229.29
• Dividend Yield: 1.50%
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:AZNCF
• CIK: 901832
• Web: www.astrazeneca.com
• Phone: 442037495000
• Fax: N/A
• Employees: 83,500
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 229.29
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A